Last reviewed 2026-04-19 · How we verify

Chronic obstructive lung disease

16 treatments

Approved treatments

Striverdi Respimat · Boehringer Ingelheim
Striverdi Respimat works by stimulating the beta-2 receptors in the lungs to relax airway muscles and improve breathing.
Yupelri · Mylan Ireland Ltd
Yupelri works by blocking the action of a chemical called acetylcholine, which stimulates the muscles in the airways, leading to bronchodilation.
Incruse Ellipta · Glaxo Grp England
Umeclidinium works by blocking the M4 muscarinic acetylcholine receptor to relax airway smooth muscle and improve breathing.
Cuvposa · Shionogi
Cuvposa works by blocking the action of a chemical called acetylcholine, which stimulates the muscarinic receptors in the body.
Breo Ellipta · Glaxo Grp Ltd
Breo Ellipta works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing.
Brovana · Lupin
Brovana works by activating the beta-2 adrenergic receptor to relax airway muscles and improve breathing.
Arnuity Ellipta · Haleon Us Holdings
Glycopyrrolate · Yonsei University
Duxil
Tudorza Pressair · Covis
DUAKLIR PRESSAIR combines aclidinium, an anticholinergic, and formoterol, a beta 2 -adrenergic agonist, to provide bronchodilation in COPD.
Atrovent
Oxytropium Bromide
Oxytropium works by blocking the action of acetylcholine, a neurotransmitter that causes airway muscles to contract.
UMEC · Glaxo Grp England
UmeC is a small molecule drug that works by interacting with a specific target in the body.
Incruse · Fundacio Privada Mon Clinic Barcelona
Brovana · Wake Forest University Health Sciences
Sialanar · Proveca Pharma Limited

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

Chronic obstructive lung disease patent landscape — cliff calendar, originator estates, attackable patents
Chronic obstructive lung disease treatment landscape brief
Chronic obstructive lung disease treatment updates RSS

Frequently asked questions about Chronic obstructive lung disease

What drugs treat Chronic obstructive lung disease?

Tracked treatments include Striverdi Respimat, Yupelri, Incruse Ellipta, Cuvposa, Breo Ellipta, Brovana, Arnuity Ellipta, Glycopyrrolate.

What is the treatment for Chronic obstructive lung disease?

Standard treatment for Chronic obstructive lung disease includes Striverdi Respimat, Yupelri, Incruse Ellipta, Cuvposa, Breo Ellipta. See the treatment landscape page for first-line, second-line and salvage options.

Treatment landscape: Chronic obstructive lung disease patent cliff · Chronic obstructive lung disease CI report
Treatment: Striverdi Respimat · Boehringer Ingelheim
Treatment: Yupelri · Mylan Ireland Ltd
Treatment: Incruse Ellipta · Glaxo Grp England
Treatment: Cuvposa · Shionogi
Treatment: Breo Ellipta · Glaxo Grp Ltd
All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing